2011
DOI: 10.1016/j.transproceed.2011.08.041
|View full text |Cite
|
Sign up to set email alerts
|

Intrauterine Hypotrophy and Premature Births in Neonates Delivered by Female Renal and Liver Transplant Recipients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
7
0
1

Year Published

2013
2013
2021
2021

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 15 publications
(8 citation statements)
references
References 11 publications
0
7
0
1
Order By: Relevance
“…A detailed analysis of the literature shows that mothers from different groups have used varied immunosuppressive schemes (3,(7)(8)(9)31,(34)(35)(36). Currently, three drugs are used-one calcineurin inhibitor, one corticosteroid and one antiproliferative agent, usually azathioprine or mycophenolic acid (37).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…A detailed analysis of the literature shows that mothers from different groups have used varied immunosuppressive schemes (3,(7)(8)(9)31,(34)(35)(36). Currently, three drugs are used-one calcineurin inhibitor, one corticosteroid and one antiproliferative agent, usually azathioprine or mycophenolic acid (37).…”
Section: Discussionmentioning
confidence: 99%
“…Pregnancy in these women has become possible and children born to female kidney recipients are increasingly more frequent (4,5). Most research on this population has focused attention on prematurity and low birth weight, which are often observed among children born to female kidney recipients (6,7).…”
Section: Introductionmentioning
confidence: 99%
“…This is likely to be a result of proteinuria and hypertension, which are more common in this group; however, in our sample, we were unable to statistically confirm the dependence between proteinuria and occurrence of IUGR. Kociszewska-Najman et al [5] compared neonatal outcomes (including IUGR and premature delivery) in patients after liver and kidney transplantation. Interestingly they confirmed that the prevalence of adverse neonatal outcomes is higher in mothers after kidney transplantation.…”
Section: Discussionmentioning
confidence: 99%
“…These medications pass the placenta and are absorbed into the fetal circulation, which may lead to adverse effects [3]. The existing studies do not show an increased risk of embryopathy, but the incidence of prematurity, low birth weight, and hypotrophy is proven to be higher [3,9]. The remote impact of that kind of treatment on the immune system has not yet been established.…”
Section: Discussionmentioning
confidence: 99%